The first 1,000 days of an infant’s life are critical. In that window from conception to a child’s second birthday, the availability of certain nutrients has lasting effects on everything from the brain to the immune system. That understanding has reinforced the need for infant formula that provides all the benefits of breastmilk. DSM is responding to that need by investing in human milk oligosaccharides (HMOs) to eliminate one of the major differences between breastmilk and infant formula.
You May Also Like

Global conference on infant nutrition in Wellington
INCOctober 17, 2022

US formula shortage: FDA refutes claims of postponing all applications under discretion policy
INCAugust 30, 2022

‘Possible opportunity’: ANZ infant nutrition firms gear up for US market entry amid formula shortage
INCJune 27, 2022